Prospective study of an ultra-lightweight polypropylene Y mesh for robotic sacrocolpopexy

Charbel Salamon, Christa Lewis, Jennifer Priestley, Emil Gurshumov, Patrick J. Culligan

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Introduction and hypothesis To prospectively evaluate the use of a particular polypropylene Y mesh for robotic sacrocolpopexy. Methods This was a prospective study of 120 patients who underwent robotic sacrocolpopexy. We compared preoperative and 12-month postoperative objective and subjective assessments via the Pelvic Organ Prolapse Quantification (POP-Q), the Pelvic Floor Distress Inventory, Short Form 20 (PFDI-20); the Pelvic Floor Impact Questionnaire, Short Form 7 (PFIQ-7); and the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire 12 (PISQ-12). Objective "anatomical success" was defined as POP-Q stage 0 or 1 at all postoperative intervals. We further defined "clinical cure" by simultaneously considering POP-Q points and subjective measures. To be considered a "clinical cure," a given patient had to have all POP-Q points =0, apical POP-Q point C =5, no reported pelvic organ prolapse symptoms on the PFDI-20, and no reoperation for prolapse at all postoperative intervals. Results Of the 120 patients, 118 patients completed the 1-year follow-up. The objective"anatomical success" rate was 89 % and the "clinical cure" rate was 94 %. The PFDI- 20 mean score improved from 100.4 at baseline to 21.0 at 12 months (p<0.0001); PFIQ-7 scores improved from 61.6 to 8.0 (p<0.0001); and PISQ-12 scores improved from 35.7 to 38.6 (p<0.0009). No mesh erosions or mesh-related complications occurred. Conclusion The use of this ultra-lightweight Y mesh for sacrocolpopexy, eliminated the mesh-related complications in the first postoperative year, and provided significant improvement in subjective and objective outcomes.

Original languageEnglish (US)
Pages (from-to)1371-1375
Number of pages5
JournalInternational Urogynecology Journal and Pelvic Floor Dysfunction
Volume24
Issue number8
DOIs
StatePublished - Aug 1 2013
Externally publishedYes

Fingerprint

Pelvic Organ Prolapse
Polypropylenes
Robotics
Prospective Studies
Pelvic Floor
Prolapse
Urinary Incontinence
Equipment and Supplies
Reoperation
Surveys and Questionnaires

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynecology
  • Urology

Cite this

Salamon, Charbel ; Lewis, Christa ; Priestley, Jennifer ; Gurshumov, Emil ; Culligan, Patrick J. / Prospective study of an ultra-lightweight polypropylene Y mesh for robotic sacrocolpopexy. In: International Urogynecology Journal and Pelvic Floor Dysfunction. 2013 ; Vol. 24, No. 8. pp. 1371-1375.
@article{b0ab8c5d1bb64f4892d13da40268bffb,
title = "Prospective study of an ultra-lightweight polypropylene Y mesh for robotic sacrocolpopexy",
abstract = "Introduction and hypothesis To prospectively evaluate the use of a particular polypropylene Y mesh for robotic sacrocolpopexy. Methods This was a prospective study of 120 patients who underwent robotic sacrocolpopexy. We compared preoperative and 12-month postoperative objective and subjective assessments via the Pelvic Organ Prolapse Quantification (POP-Q), the Pelvic Floor Distress Inventory, Short Form 20 (PFDI-20); the Pelvic Floor Impact Questionnaire, Short Form 7 (PFIQ-7); and the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire 12 (PISQ-12). Objective {"}anatomical success{"} was defined as POP-Q stage 0 or 1 at all postoperative intervals. We further defined {"}clinical cure{"} by simultaneously considering POP-Q points and subjective measures. To be considered a {"}clinical cure,{"} a given patient had to have all POP-Q points =0, apical POP-Q point C =5, no reported pelvic organ prolapse symptoms on the PFDI-20, and no reoperation for prolapse at all postoperative intervals. Results Of the 120 patients, 118 patients completed the 1-year follow-up. The objective{"}anatomical success{"} rate was 89 {\%} and the {"}clinical cure{"} rate was 94 {\%}. The PFDI- 20 mean score improved from 100.4 at baseline to 21.0 at 12 months (p<0.0001); PFIQ-7 scores improved from 61.6 to 8.0 (p<0.0001); and PISQ-12 scores improved from 35.7 to 38.6 (p<0.0009). No mesh erosions or mesh-related complications occurred. Conclusion The use of this ultra-lightweight Y mesh for sacrocolpopexy, eliminated the mesh-related complications in the first postoperative year, and provided significant improvement in subjective and objective outcomes.",
author = "Charbel Salamon and Christa Lewis and Jennifer Priestley and Emil Gurshumov and Culligan, {Patrick J.}",
year = "2013",
month = "8",
day = "1",
doi = "10.1007/s00192-012-2021-7",
language = "English (US)",
volume = "24",
pages = "1371--1375",
journal = "International Urogynecology Journal and Pelvic Floor Dysfunction",
issn = "0937-3462",
publisher = "Springer London",
number = "8",

}

Prospective study of an ultra-lightweight polypropylene Y mesh for robotic sacrocolpopexy. / Salamon, Charbel; Lewis, Christa; Priestley, Jennifer; Gurshumov, Emil; Culligan, Patrick J.

In: International Urogynecology Journal and Pelvic Floor Dysfunction, Vol. 24, No. 8, 01.08.2013, p. 1371-1375.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prospective study of an ultra-lightweight polypropylene Y mesh for robotic sacrocolpopexy

AU - Salamon, Charbel

AU - Lewis, Christa

AU - Priestley, Jennifer

AU - Gurshumov, Emil

AU - Culligan, Patrick J.

PY - 2013/8/1

Y1 - 2013/8/1

N2 - Introduction and hypothesis To prospectively evaluate the use of a particular polypropylene Y mesh for robotic sacrocolpopexy. Methods This was a prospective study of 120 patients who underwent robotic sacrocolpopexy. We compared preoperative and 12-month postoperative objective and subjective assessments via the Pelvic Organ Prolapse Quantification (POP-Q), the Pelvic Floor Distress Inventory, Short Form 20 (PFDI-20); the Pelvic Floor Impact Questionnaire, Short Form 7 (PFIQ-7); and the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire 12 (PISQ-12). Objective "anatomical success" was defined as POP-Q stage 0 or 1 at all postoperative intervals. We further defined "clinical cure" by simultaneously considering POP-Q points and subjective measures. To be considered a "clinical cure," a given patient had to have all POP-Q points =0, apical POP-Q point C =5, no reported pelvic organ prolapse symptoms on the PFDI-20, and no reoperation for prolapse at all postoperative intervals. Results Of the 120 patients, 118 patients completed the 1-year follow-up. The objective"anatomical success" rate was 89 % and the "clinical cure" rate was 94 %. The PFDI- 20 mean score improved from 100.4 at baseline to 21.0 at 12 months (p<0.0001); PFIQ-7 scores improved from 61.6 to 8.0 (p<0.0001); and PISQ-12 scores improved from 35.7 to 38.6 (p<0.0009). No mesh erosions or mesh-related complications occurred. Conclusion The use of this ultra-lightweight Y mesh for sacrocolpopexy, eliminated the mesh-related complications in the first postoperative year, and provided significant improvement in subjective and objective outcomes.

AB - Introduction and hypothesis To prospectively evaluate the use of a particular polypropylene Y mesh for robotic sacrocolpopexy. Methods This was a prospective study of 120 patients who underwent robotic sacrocolpopexy. We compared preoperative and 12-month postoperative objective and subjective assessments via the Pelvic Organ Prolapse Quantification (POP-Q), the Pelvic Floor Distress Inventory, Short Form 20 (PFDI-20); the Pelvic Floor Impact Questionnaire, Short Form 7 (PFIQ-7); and the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire 12 (PISQ-12). Objective "anatomical success" was defined as POP-Q stage 0 or 1 at all postoperative intervals. We further defined "clinical cure" by simultaneously considering POP-Q points and subjective measures. To be considered a "clinical cure," a given patient had to have all POP-Q points =0, apical POP-Q point C =5, no reported pelvic organ prolapse symptoms on the PFDI-20, and no reoperation for prolapse at all postoperative intervals. Results Of the 120 patients, 118 patients completed the 1-year follow-up. The objective"anatomical success" rate was 89 % and the "clinical cure" rate was 94 %. The PFDI- 20 mean score improved from 100.4 at baseline to 21.0 at 12 months (p<0.0001); PFIQ-7 scores improved from 61.6 to 8.0 (p<0.0001); and PISQ-12 scores improved from 35.7 to 38.6 (p<0.0009). No mesh erosions or mesh-related complications occurred. Conclusion The use of this ultra-lightweight Y mesh for sacrocolpopexy, eliminated the mesh-related complications in the first postoperative year, and provided significant improvement in subjective and objective outcomes.

UR - http://www.scopus.com/inward/record.url?scp=84892403375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892403375&partnerID=8YFLogxK

U2 - 10.1007/s00192-012-2021-7

DO - 10.1007/s00192-012-2021-7

M3 - Article

C2 - 23296684

AN - SCOPUS:84892403375

VL - 24

SP - 1371

EP - 1375

JO - International Urogynecology Journal and Pelvic Floor Dysfunction

JF - International Urogynecology Journal and Pelvic Floor Dysfunction

SN - 0937-3462

IS - 8

ER -